(RW)3

General Information


DRACP ID  DRACP00448

Peptide Name   (RW)3

Sequence  RWRWRW

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma IC50=143±21µM Resazurin assay 48h 1
HT-29 Colon adenocarcinoma Carcinoma IC50=132±12µM Resazurin assay 48h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=159±7µM Resazurin assay 48h 1

Hemolytic Activity  Sheep erythrocytes: 50% Hemolysis=210 µM; Human erythrocytes: 17% Hemolysis=333 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00448

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C51H68N18O7

Absent amino acids  ACDEFGHIKLMNPQSTVY

Common amino acids  RW

Mass  113457

Pl  12.8

Basic residues  3

Acidic residues  0

Hydrophobic residues  3

Net charge  3

Boman Index  -3777

Hydrophobicity  -270

Aliphatic Index  0

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  16500

Absorbance 280nm  3300

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23209509

Title  Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups

Doi 10.3762/bjoc.8.200

Year  2012

Literature 2

Pubmed ID 17145799

Title  Length effects in antimicrobial peptides of the (RW)n series

Doi 10.1128/AAC.00828-06

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.